Close Menu

Laboratory Corporation of America

Covance hopes to improve and accelerate oncology clinical trial matching with the Tempus technology platform and network.

The firm will use the proceeds to further a validation study  tracking the ability of its cell culture assay to predict patient response to cancer therapies.